Dr Phillip Stricker

Prof Stricker, the chief investigator on the current Active Surveillance trial, said that the trial is running extremely well and accruing valuable data rapidly. 

For distinguished service to medicine and medical research, as a leading urologist, a robotic surgery pioneer, a teacher and mentor, and as an advocate for prostate cancer awareness.

A recent publication by Prof Stricker's and Prof Emberton's group in the journal Prostate Cancer and Prostate Diseases confirmed the safety of NanoKnife focal therapy in prostate cancer.

Prof Stricker and Louise Emmett have been instrumental in beginning a choline PET scan imaging which allows patients to find microscopic disease in lymph glands beyond the prostate.